Navigation Links
Nventa in Medical News

Nventa announces change in Board of Directors

...her Board positions, was a tremendous asset to the nventa Board. We will miss her and wish her continued suc...l trial in women with cervical dysplasia." About nventa Biopharmaceuticals Corporation: nventa is developing innovative therapeutics for the trea...

Nventa presents HspE7 data at international HPV conference

...eek in Beijing, China. HspE7 is being developed by nventa as a therapeutic vaccine for the treatment of dise... of action that is needed to clear the infection. nventa has previously shown that HspE7, a proprietary the... and activating cells of the immune system. About nventa Corporation: ------------------------- ...

Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc.

...ies Inc. As a financier, Mr. Meekison has raised equity capital for various biotechnology companies such as StressGen Biotechnologies Corporation (now nventa Biopharmaceuticals Corporation), ID Biomedical Corp., Salix Pharmaceuticals Inc., Acorda Therapeutics Inc., Inex Pharmaceuticals Corporation, Nortran ...
Nventa in Medical Technology

Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress

...vant SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today pr... Poly-ICR into future internal product candidates, nventa is pursuing the development of Poly-ICR for topica...l evolve into a revenue generating opportunity for nventa in the near future." About Poly-ICR: Poly-ICR ...

Nventa Develops Proprietary Vaccine Adjuvant

...ist SAN DIEGO, June 18 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...s its consistency in physical-chemical properties. nventa has successfully manufactured research and develop...ccines against targeted antigens and pathogens." nventa intends to incorporate Poly-ICR into its future Co...

Nventa to Present at Bio 2008 International Convention

... SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) announce...rld. The presentation will not be webcast. About nventa Biopharmaceuticals Corporation: nventa is developing innovative therapeutics for the trea...

Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial

...spE7 SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...nical responses in patients with CIN. Accordingly, nventa believes that HspE7 may successfully induce a targ...le for a significant percentage of cases of CIN. nventa is currently working with the U.S. Food and Drug A...

Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial

... - SAN DIEGO, April 24 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...linical responses in patients with CIN. Therefore, nventa believes that HspE7 may successfully treat CIN by ...ate enrollment by mid-2008." In addition to CIN, nventa is currently evaluating HspE7 as a potential treat...

Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial

...it SAN DIEGO, March 26 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...ngs will be released in the next several months. nventa is currently working with the FDA to finalize tria...n patients in CIN in mid-2008. In addition to CIN, nventa is currently evaluating HspE7 as a potential treat...

Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial

... SAN DIEGO, March 11 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...reby stimulating cellular immune system responses. nventa is developing new HspE7 for multiple indications. About nventa Corporation: ...

Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial

...y - SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an... is expected shortly. At the end of each cohort, nventa is also collecting immunological data that may pro...reby stimulating cellular immune system responses. nventa is developing HspE7 + Poly-ICLC for multiple indic...

Initiation of Coverage Informational Review Issued by Scimitar Equity Research

... Scimitar Equity Research, Inc. issues a review on nventa Biopharmaceuticals Corporation (TSX: NVN) entitled... website: http://www.scimitarequity.com . About nventa Corporation: nventa is developing innovative therapeutics for the trea...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

...n cells and activating cells of the immune system. nventa is pursuing clinical development of HspE7 in combination with an adjuvant. About nventa Corporation: ------------------------- nventa is developing innovative therapeutics for the trea...
Nventa in Biological Technology

Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights

... SAN DIEGO, Nov. 11 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) today an...her human papillomavirus (HPV) therapeutics. o nventa presented positive data from preclinical studies u...d 11 target antigens. "During the quarter, nventa announced positive clinical results for our lead c...

Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR

... M&A SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN), a compa...nt for both therapeutic and prophylactic vaccines. nventa is currently advancing Poly-ICR as a means for rev... internal development. -- Partnering Poly-ICR -- nventa is currently providing Poly-ICR through Material T...

Nventa Appoints Gordon H. Busenbark to Board of Directors

...ce - SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) announce...in corporate finance and manufacturing, will serve nventa well as we continue to advance our lead product ca...ard to collaborating with the other members of the nventa board and leveraging my industry experience to hel...

Nventa Appoints John Varian to Board of Directors

...ise - SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation (TSX: NVN) announce...and acquisitions should be extremely beneficial to nventa as it grows internally and continues its path to c...nal Conference. "I am proud to join the board at nventa Biopharmaceuticals, a truly innovative company tha...

Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results

... - SAN DIEGO, March 13 /PRNewswire-FirstCall/ -- nventa Biopharmaceuticals Corporation announced today fin...ess specified otherwise, are in Canadian dollars. nventa reported a net loss of $12,413,000, or $0.06 per s..., which generated gross proceeds of $24,807,000. nventa also reported a net loss of $2,319,000, or $0.01 p...

Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial

...In addition to safety and tolerability assessment, nventa will also collect immunological data from these pa...and activating cells of the immune system. About nventa Corporation: ------------------------- nventa is developing innovative therapeutics for the trea...

Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results

...ess specified otherwise, are in Canadian dollars. nventa reported a net loss of $3.1 million or $0.01 per s...of $14.3 million as of September 30, 2007. RECENT nventa HIGHLIGHTS - Initiated and dosed the first coh...progress our preclinical pipeline as well." About nventa Biopharmaceuticals Corporation: -----------------...

Nventa updates progress of cervical dysplasia trial with new HspE7

...In addition to safety and tolerability assessment, nventa will also collect immunological data from these pa... and activating cells of the immune system. About nventa Corporation: ------------------------- nventa is developing innovative therapeutics for the trea...

Nventa's CEO to present at two upcoming investor conferences

...emove any extra spaces if necessary.) About nventa Biopharmaceuticals Corporation: -------------------------------------------- nventa is developing innovative therapeutics for the trea... under the symbol NVN. For more information about nventa Biopharmaceuticals Corporation and access to the B...

Nventa announces publication of HspE7 data

...ng clinical development of new HspE7 (HspE7 dosed with an adjuvant). About nventa Corporation: ------------------------- nventa is developing innovative therapeutics for the treatment of viral infections...
Other Tags
(Date:1/22/2015)... 22, 2015 Gabe’s Chemo Duck Program is pleased ... first app ever created for kids with cancer. The Chemo Duck ... devices, is filled with enjoyable games to help children of all ... free app helps to keep kids entertained, educated and at ease ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
(Date:1/22/2015)... , Europe,s most prestigious ... Office to present a video retrospective of the most exciting and ... Christofer Toumazou and Sophie Wilson   A ... Award   Starting on 22 January 2015 on   http://www.epo.org/european-inventor ...
(Date:12/22/2014)... Inc. (NASDAQ: NXTD and NXTDW) ("NXT-ID" or ... mobile commerce market, announces it has retained famous pickpocket, entertainer ... International CES debut of the Wocket™ biometric smart wallet.  ... NXT-ID booth January 6th and 7 th , 2015, demonstrating ...
(Date:12/19/2014)... VIEW, Calif. , Dec. 18, 2014  23andMe, Inc., the ... study that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four hundred years ... as a meeting place for peoples from different continents. This ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
Other Contents